Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80+: A Five-Year Follow-Up Study
Open Access
- 10 November 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (11) , e0142123
Abstract
Polypharmacy is a problem of growing interest in geriatrics with the increase in drug consumption in recent years, is defined according to the WHO criteria as the, ‘‘concurrent use of five or more different prescription medication”. We investigated the clinical characteristics of polypharmacy and identified the effects of polypharmacy on clinical outcome among patients aged 80+ admitted to Chinese PLA general hospital. Older men aged ≥80 years (n = 1562) were included in this study. The included participants attended a structured clinical examination and an interview carried out by a geriatrician and trained nurses. A follow-up survey in 2014 was carried out on survivors in the same way as in 2009. The clinical outcome measured were adverse drug reactions, falls, frailty, disability, cognitive impairment, mortality. The association between polypharmacy and clinical outcome was assessed by logistic regression. The mean (range) age of the included participants was 85.2 (80–104) years. Medication exposure was reported by 100% of the population. Mean number of medications reported in this population was 9.56±5.68. The prevalence of polypharmacy (≥6 medications) in the present study was 70%. At the time of the follow-up survey, an increase in the number of taken medicines had occurred among half of the survivors. The risk of different outcomes in relation to number of medications rises significantly, the odds ratios were 1.21 (95% confidence interval [CI]1.17–1.28) for adverse drug reactions, 1.18 (95% CI 1.10–1.26) for falls, 1.16 (95% CI 1.09–1.24) for disability, and 1.19 (95% CI 1.12–1.23) for mortality. There was no association between increasing number of medications and cognitive impairment. Our study demonstrates that polypharmacy is very common in the very old patients, and observed that number of medications was a factor associated with difference clinical outcome independently of the age, type of medications prescribed and accompanied comorbidities.Keywords
This publication has 31 references indexed in Scilit:
- Clinical consequences of polypharmacy in elderlyExpert Opinion on Drug Safety, 2013
- Factors associated with falls among older adults living in institutionsBMC Geriatrics, 2013
- Pharmacoepidemiology in the Postmarketing Assessment of the Safety and Efficacy of Drugs in Older AdultsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Association of polypharmacy with fall risk among geriatric outpatientsGeriatrics & Gerontology International, 2011
- Urinary incontinence: An under‐recognized risk factor for falls among elderly dementia patientsNeurourology and Urodynamics, 2011
- Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic ConditionsPLOS ONE, 2010
- Polypharmacy Correlates With Increased Risk for Hip Fracture in the ElderlyMedicine, 2010
- Adverse drug events in the outpatient setting: an 11‐year national analysisPharmacoepidemiology and Drug Safety, 2010
- Polypharmacy and falls in the middle age and elderly populationBritish Journal of Clinical Pharmacology, 2005
- Health Outcomes and Polypharmacy in Elderly IndividualsJournal of Gerontological Nursing, 2005